Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/65488
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Nilotinib does not significantly reduce imatinib OCT-1 activity in either cell lines or primary CML cells |
Author: | Eadie, L. Hughes, T. White, D. |
Citation: | Leukemia, 2010; 24(4):855-857 |
Publisher: | Nature Publishing Group |
Issue Date: | 2010 |
ISSN: | 0887-6924 1476-5551 |
Statement of Responsibility: | L. Eadie, T. P. Hughes and D. L. White |
Keywords: | Tumor Cells, Cultured Humans Benzamides Tetraethylammonium Piperazines Pyrimidines Prazosin Adrenergic alpha-Antagonists Protein Kinase Inhibitors Drug Therapy, Combination Octamer Transcription Factor-1 Protein-Tyrosine Kinases Leukemia, Myelogenous, Chronic, BCR-ABL Positive Imatinib Mesylate |
Rights: | © 2011 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |
DOI: | 10.1038/leu.2010.7 |
Published version: | http://dx.doi.org/10.1038/leu.2010.7 |
Appears in Collections: | Agriculture, Food and Wine publications Aurora harvest |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.